Injectable and inhalable drugs will be subject to physical examination and testing regardless of their place of origin within Japan because these drugs more directly enter into the bloodstream. All other drugs originating from outside of the ten prefectures in closest proximity to the Fukushima Daiichi nuclear plant will be subject to normal processing for examination, sampling, and testing.
